Peptide Research Reference

Research dosing ranges, reconstitution protocols, administration routes, and study applications for compounds available through Blackwell BioLabs. All information is drawn from published academic and clinical research.

For Research Use Only. Not for Human Consumption.

All compounds on this page are sold strictly for in vitro research and laboratory use. Dosing ranges reflect values studied in published academic and clinical literature and are provided for reference purposes only. This is not medical advice, and no information on this page should be construed as a recommendation for human use. Consult a licensed healthcare provider before making any health-related decisions.

Research Range: dosing values studied in published literature
Peptide Calculator
🩹 Healing & Recovery
4 compounds

BPC-157

Body Protection Compound

SubQ / OralDaily
Research Range200 – 500 mcg

Range studied in published research

TB-500

Thymosin Beta-4 fragment

SubQ / IM2x/week
Research Range2.5 – 5 mg

Range studied in published research

GHK-Cu

Copper peptide tripeptide

SubQ / TopicalDaily
Research Range1 – 2 mg

Range studied in published research

KPV

Alpha-MSH tripeptide fragment

SubQ / OralDaily
Research Range100 – 500 mcg

Range studied in published research

🧬 Growth Hormone
3 compounds

CJC-1295 w/DAC

GHRH analog with drug affinity complex

SubQ1x/week
Research Range1 – 2 mg

Range studied in published research

Ipamorelin

Selective growth hormone secretagogue

SubQ2-3x daily
Research Range200 – 300 mcg

Range studied in published research

Tesamorelin

GHRH analog, FDA-approved

FDA Approved
SubQDaily
Research Range1 – 2 mg

Range studied in published research

🔥 Metabolic
2 compounds

Retatrutide

Triple GLP-1/GIP/Glucagon receptor agonist

SubQWeekly
Research Range2 – 8 mg

Range studied in published research

MOTS-c

Mitochondrial-derived peptide

SubQ2-3x/week
Research Range5 – 10 mg

Range studied in published research

🧠 Cognitive & Neuro
5 compounds

Selank

Tuftsin analog anxiolytic peptide

Intranasal / SubQ1-2x daily
Research Range250 – 500 mcg

Range studied in published research

Semax

ACTH analog nootropic peptide

Intranasal1-3x daily
Research Range300 – 900 mcg

Range studied in published research

Dihexa

HGF/MET system modulator

Preclinical
OralDaily
Research Range1 – 3 mg

Range studied in published research

Cerebrolysin

Neuropeptide complex

IM / IVDaily (cycled)
Research Range5 – 10 mL

Range studied in published research

DSIP

Delta sleep-inducing peptide

SubQNightly
Research Range100 – 400 mcg

Range studied in published research

Longevity & Cellular
3 compounds

NAD+

Nicotinamide adenine dinucleotide

IV / SubQ / OralDaily-Weekly
Research Range250 – 500 mg

Range studied in published research

Epithalon

Tetrapeptide telomere research compound

SubQ / IVDaily (cycled)
Research Range5 – 10 mg

Range studied in published research

SS-31

Szeto-Schiller mitochondrial peptide

Preclinical
SubQDaily
Research Range1 – 10 mg

Range studied in published research

Common Research Protocols

Compound combinations frequently appearing together in published research.

Recovery Protocol

BPC-157TB-500

BPC-157 and TB-500 are frequently co-administered in tissue repair studies. BPC-157 targets localized repair while TB-500 supports systemic recovery and connective tissue remodeling.

GH Axis Research

CJC-1295 w/DACIpamorelin

A GHRH analog combined with a selective GHRP. CJC-1295 with DAC provides extended GH release; Ipamorelin adds selective pulsatile stimulation without cortisol or prolactin elevation.

Cognitive Research Stack

SemaxSelank

Semax and Selank are often studied together. Semax upregulates BDNF and supports cognitive performance; Selank provides anxiolytic modulation through the HPA axis.

Longevity Protocol

EpithalonGHK-CuNAD+MOTS-c

A multi-target longevity protocol. Epithalon addresses telomere biology, GHK-Cu supports tissue regeneration, NAD+ targets mitochondrial metabolism, and MOTS-c activates AMPK pathways.

Metabolic Research Protocol

RetatrutideTesamorelin

Retatrutide as a triple agonist for metabolic dysfunction research, combined with Tesamorelin for visceral adipose tissue reduction and GH axis support.

Sleep and Recovery Protocol

DSIPBPC-157Ipamorelin

DSIP promotes slow-wave sleep architecture, BPC-157 supports overnight tissue repair, and Ipamorelin provides a nocturnal GH pulse. All three are studied in overnight recovery contexts.

For Research & Educational Purposes Only · Not Medical Advice · Not for Human Consumption · blackwellbiolabs.com